• Chris Bunka, the Chairman and CEO of Lexaria, featured on the EDGE podcast hosted by Brandon C. White
• He provided insight into his background, professional philosophies, and Lexaria’s operations, with a focus on the company’s patented DehydraTECH(TM) technology
• Mr. Bunka also advised small companies and entrepreneurs, citing the importance of understanding the competitive environment

Chris Bunka, the Chairman and Chief Executive Officer (“CEO”) of Lexaria Bioscience (NASDAQ: LEXX), was recently featured on episode 234 of the EDGE Podcast. Hosted by Brandon C. White, an Angel Investor and Entrepreneur, Mr. Bunka shared insights into his professional journey while also sharing what the company is committed to achieving going forward. 

Mr. Bunka lauded the company’s patented DehydraTECH(TM) technology, citing how integral it is to improve the delivery of active pharmaceutical ingredients and other fat-soluble molecules.  So far, this technology has proven promising for the potential treatment of hypertension and heart disease, and is already being sublicensed for the delivery of CBD.

“Our technology is all about enabling a much higher fraction and a much smoother delivery of the beneficial substances in the foods you eat and in the drugs you take and, quite frankly, getting them into your bloodstream,” he noted (https://ibn.fm/kGRDm).

He also walked the audience through his career growth that spans over four decades, having started his first business at the age of 17. Over the years, he notes, he has learned how to run a business, rely on other people, and manage employees, skills that have translated to the success of Lexaria thus far.

When asked about his most significant career lessons, Mr. Bunka reckoned that while he has learned a lot, the central aspect is the significance of understanding the competitive environment. He further advised small companies and entrepreneurs first to understand their competitive environment and then understand the products and services they offer to customers.

“A lot of small companies don’t do a good job of understanding their competitive environment,” he noted. “A lot of them say, ‘I’m the best, I’m the fastest.’…I could be on my laptop and have somebody pitching me on an idea, and I see 3,700 companies just like his. It makes it really hard, so understanding your competitive environment is really, really important, as well as understanding your products and services,” he added.

The interview with Mr. Bunka offered a glimpse into the inner workings of Lexaria, the vision that he has for the company, and the goals that it is working towards. In addition, he talked about the company’s ongoing efforts to make the most out of its innovative delivery platform, along with professional philosophies that have guided his career so far.

You can listen to the entire interview here https://ibn.fm/3QMBD

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.